Data from Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.c.6504870.v1
Cancer immunosurveillance relies on effector/memory tumor-infiltrating CD8+ T cells with a T-helper cell 1 (TH1) profile. Evidence for a natural killer (NK) cell-based control of human malignancies is still largely missing. The KIT tyrosine kinase inhibitor imatinib mesylate markedly prolongs the survival of patients with gastrointestinal stromal tumors (GIST) by direct effects on tumor cells as well as by indirect immunostimulatory effects on T and NK cells. Here, we investigated the prognostic value of tumor-infiltrating lymphocytes (TIL) expressing CD3, Foxp3, or NKp46 (NCR1) in a cohort of patients with localized GIST. We found that CD3+ TIL were highly activated in GIST and were especially enriched in areas of the tumor that conserve class I MHC expression despite imatinib mesylate treatment. High densities of CD3+ TIL predicted progression-free survival (PFS) in multivariate analyses. Moreover, GIST were infiltrated by a homogeneous subset of cytokine-secreting CD56bright (NCAM1) NK cells that accumulated in tumor foci after imatinib mesylate treatment. The density of the NK infiltrate independently predicted PFS and added prognostic information to the Miettinen score, as well as to the KIT mutational status. NK and T lymphocytes preferentially distributed to distinct areas of tumor sections and probably contributed independently to GIST immunosurveillance. These findings encourage the prospective validation of immune biomarkers for optimal risk stratification of patients with GIST. Cancer Res; 73(12); 3499–510. ©2013 AACR.
Related Topics
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.c.6504870.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392686522
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392686522Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.c.6504870.v1Digital Object Identifier
- Title
-
Data from Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal TumorsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-30Full publication date if available
- Authors
-
Sylvie Rusakiewicz, Michaëla Semeraro, Matthieu Sarabi, Mélanie Desbois, Clara Locher, R. Méndez, Nadège Vimond, Ángel Concha, Federico Garrido, Nicolás Isambert, L. Chaigneau, Valérie Le Brun-Ly, Patrice Dubreuil, Isabelle Cremer, Anne Caignard, Vichnou Poirier-Colame, Kariman Chaba, Caroline Flament, Niels Halama, Dirk Jäger, Alexander Eggermont, Sylvie Bonvalot, Frédéric Commo, Philippe Terrier, Paule Opolon, Jean‐François Emile, Jean‐Michel Coindre, Guido Kroemer, Nathalie Chaput, Axel Le Cesne, Jean‐Yves Blay, Laurence ZitvogelList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.c.6504870.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/0008-5472.c.6504870.v1Direct OA link when available
- Concepts
-
Stromal cell, Immune system, Medicine, Pathology, ImmunologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392686522 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| ids.doi | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| ids.openalex | https://openalex.org/W4392686522 |
| fwci | 0.0 |
| type | preprint |
| title | Data from Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11485 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2715 |
| topics[0].subfield.display_name | Gastroenterology |
| topics[0].display_name | Gastrointestinal Tumor Research and Treatment |
| topics[1].id | https://openalex.org/T11855 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9965999722480774 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Gastrointestinal disorders and treatments |
| topics[2].id | https://openalex.org/T11020 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9794999957084656 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune Cell Function and Interaction |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C16930146 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7947360277175903 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4381253 |
| concepts[0].display_name | Stromal cell |
| concepts[1].id | https://openalex.org/C8891405 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6751068830490112 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[1].display_name | Immune system |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.524291455745697 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C142724271 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4489877223968506 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[3].display_name | Pathology |
| concepts[4].id | https://openalex.org/C203014093 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3528149724006653 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[4].display_name | Immunology |
| keywords[0].id | https://openalex.org/keywords/stromal-cell |
| keywords[0].score | 0.7947360277175903 |
| keywords[0].display_name | Stromal cell |
| keywords[1].id | https://openalex.org/keywords/immune-system |
| keywords[1].score | 0.6751068830490112 |
| keywords[1].display_name | Immune system |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.524291455745697 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/pathology |
| keywords[3].score | 0.4489877223968506 |
| keywords[3].display_name | Pathology |
| keywords[4].id | https://openalex.org/keywords/immunology |
| keywords[4].score | 0.3528149724006653 |
| keywords[4].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.c.6504870.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5013921145 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5939-5690 |
| authorships[0].author.display_name | Sylvie Rusakiewicz |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sylvie Rusakiewicz |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5017005000 |
| authorships[1].author.orcid | https://orcid.org/0009-0005-7255-1922 |
| authorships[1].author.display_name | Michaëla Semeraro |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Michaela Semeraro |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5022977681 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4588-0585 |
| authorships[2].author.display_name | Matthieu Sarabi |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Matthieu Sarabi |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5012214419 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-5503-8821 |
| authorships[3].author.display_name | Mélanie Desbois |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Mélanie Desbois |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5057516732 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-8212-4351 |
| authorships[4].author.display_name | Clara Locher |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Clara Locher |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5111506734 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | R. Méndez |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Rosa Mendez |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5084684463 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8596-0016 |
| authorships[6].author.display_name | Nadège Vimond |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Nadège Vimond |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5108527751 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Ángel Concha |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Angel Concha |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5091885282 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-4770-9685 |
| authorships[8].author.display_name | Federico Garrido |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Federico Garrido |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5082347575 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3596-2114 |
| authorships[9].author.display_name | Nicolás Isambert |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Nicolas Isambert |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5004823659 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-4938-9470 |
| authorships[10].author.display_name | L. Chaigneau |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Loic Chaigneau |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5091303369 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Valérie Le Brun-Ly |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Valérie Le Brun-Ly |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5056713429 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-1155-1150 |
| authorships[12].author.display_name | Patrice Dubreuil |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Patrice Dubreuil |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5012515730 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-0963-1031 |
| authorships[13].author.display_name | Isabelle Cremer |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Isabelle Cremer |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5075919552 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9923-6045 |
| authorships[14].author.display_name | Anne Caignard |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Anne Caignard |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5024902665 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Vichnou Poirier-Colame |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Vichnou Poirier-Colame |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5055214548 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Kariman Chaba |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Kariman Chaba |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5000473619 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-2584-3488 |
| authorships[17].author.display_name | Caroline Flament |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Caroline Flament |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5063203307 |
| authorships[18].author.orcid | https://orcid.org/0000-0003-0344-6027 |
| authorships[18].author.display_name | Niels Halama |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Niels Halama |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5113602946 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Dirk Jäger |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Dirk Jäger |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5103037029 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-7458-4326 |
| authorships[20].author.display_name | Alexander Eggermont |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Alexander Eggermont |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5057378575 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-9726-9732 |
| authorships[21].author.display_name | Sylvie Bonvalot |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Sylvie Bonvalot |
| authorships[21].is_corresponding | False |
| authorships[22].author.id | https://openalex.org/A5064735776 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-5049-297X |
| authorships[22].author.display_name | Frédéric Commo |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Frédéric Commo |
| authorships[22].is_corresponding | False |
| authorships[23].author.id | https://openalex.org/A5107342074 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-6741-4318 |
| authorships[23].author.display_name | Philippe Terrier |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Philippe Terrier |
| authorships[23].is_corresponding | False |
| authorships[24].author.id | https://openalex.org/A5056220279 |
| authorships[24].author.orcid | https://orcid.org/0000-0002-9758-1408 |
| authorships[24].author.display_name | Paule Opolon |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Paule Opolon |
| authorships[24].is_corresponding | False |
| authorships[25].author.id | https://openalex.org/A5106733324 |
| authorships[25].author.orcid | |
| authorships[25].author.display_name | Jean‐François Emile |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Jean-François Emile |
| authorships[25].is_corresponding | False |
| authorships[26].author.id | https://openalex.org/A5108618420 |
| authorships[26].author.orcid | |
| authorships[26].author.display_name | Jean‐Michel Coindre |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Jean-Michel Coindre |
| authorships[26].is_corresponding | False |
| authorships[27].author.id | https://openalex.org/A5075296559 |
| authorships[27].author.orcid | https://orcid.org/0000-0002-9334-4405 |
| authorships[27].author.display_name | Guido Kroemer |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Guido Kroemer |
| authorships[27].is_corresponding | False |
| authorships[28].author.id | https://openalex.org/A5031362151 |
| authorships[28].author.orcid | https://orcid.org/0000-0003-3968-8669 |
| authorships[28].author.display_name | Nathalie Chaput |
| authorships[28].author_position | middle |
| authorships[28].raw_author_name | Nathalie Chaput |
| authorships[28].is_corresponding | False |
| authorships[29].author.id | https://openalex.org/A5001102421 |
| authorships[29].author.orcid | |
| authorships[29].author.display_name | Axel Le Cesne |
| authorships[29].author_position | middle |
| authorships[29].raw_author_name | Axel Le Cesne |
| authorships[29].is_corresponding | False |
| authorships[30].author.id | https://openalex.org/A5042202815 |
| authorships[30].author.orcid | https://orcid.org/0000-0001-7190-120X |
| authorships[30].author.display_name | Jean‐Yves Blay |
| authorships[30].author_position | middle |
| authorships[30].raw_author_name | Jean-Yves Blay |
| authorships[30].is_corresponding | False |
| authorships[31].author.id | https://openalex.org/A5074612242 |
| authorships[31].author.orcid | https://orcid.org/0000-0003-1596-0998 |
| authorships[31].author.display_name | Laurence Zitvogel |
| authorships[31].author_position | last |
| authorships[31].raw_author_name | Laurence Zitvogel |
| authorships[31].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Data from Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11485 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2715 |
| primary_topic.subfield.display_name | Gastroenterology |
| primary_topic.display_name | Gastrointestinal Tumor Research and Treatment |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725, https://openalex.org/W2148612803 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/0008-5472.c.6504870.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| primary_location.id | doi:10.1158/0008-5472.c.6504870.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.c.6504870.v1 |
| publication_date | 2023-03-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 13 |
| abstract_inverted_index.I | 113 |
| abstract_inverted_index.T | 7, 63, 182 |
| abstract_inverted_index.a | 10, 18, 84, 137 |
| abstract_inverted_index.NK | 65, 144, 159, 180 |
| abstract_inverted_index.We | 91 |
| abstract_inverted_index.as | 55, 57, 172, 174 |
| abstract_inverted_index.by | 49, 58, 136 |
| abstract_inverted_index.in | 83, 99, 105, 129, 148 |
| abstract_inverted_index.is | 27 |
| abstract_inverted_index.of | 24, 42, 73, 86, 107, 122, 140, 157, 189, 205, 212 |
| abstract_inverted_index.on | 3, 52, 62 |
| abstract_inverted_index.or | 80 |
| abstract_inverted_index.to | 168, 175, 186, 196 |
| abstract_inverted_index.we | 68 |
| abstract_inverted_index.KIT | 32, 177 |
| abstract_inverted_index.MHC | 114 |
| abstract_inverted_index.PFS | 163 |
| abstract_inverted_index.TIL | 95, 124 |
| abstract_inverted_index.The | 31, 155 |
| abstract_inverted_index.and | 64, 101, 164, 181, 192 |
| abstract_inverted_index.for | 17, 208 |
| abstract_inverted_index.the | 40, 70, 108, 158, 169, 176, 202 |
| abstract_inverted_index.(NK) | 21 |
| abstract_inverted_index.CD3, | 78 |
| abstract_inverted_index.GIST | 100, 133, 197 |
| abstract_inverted_index.High | 120 |
| abstract_inverted_index.Res; | 217 |
| abstract_inverted_index.cell | 12 |
| abstract_inverted_index.foci | 150 |
| abstract_inverted_index.risk | 210 |
| abstract_inverted_index.that | 93, 110, 146 |
| abstract_inverted_index.well | 56, 173 |
| abstract_inverted_index.were | 96, 102, 134 |
| abstract_inverted_index.with | 9, 44, 88, 214 |
| abstract_inverted_index.(PFS) | 128 |
| abstract_inverted_index.(TIL) | 76 |
| abstract_inverted_index.GIST. | 90, 215 |
| abstract_inverted_index.Here, | 67 |
| abstract_inverted_index.NKp46 | 81 |
| abstract_inverted_index.These | 199 |
| abstract_inverted_index.added | 165 |
| abstract_inverted_index.after | 151 |
| abstract_inverted_index.areas | 106, 188 |
| abstract_inverted_index.cells | 8, 54, 145 |
| abstract_inverted_index.class | 112 |
| abstract_inverted_index.found | 92 |
| abstract_inverted_index.human | 25 |
| abstract_inverted_index.still | 28 |
| abstract_inverted_index.tumor | 53, 109, 149, 190 |
| abstract_inverted_index.value | 72 |
| abstract_inverted_index.(GIST) | 48 |
| abstract_inverted_index.(NCR1) | 82 |
| abstract_inverted_index.Foxp3, | 79 |
| abstract_inverted_index.cells. | 66 |
| abstract_inverted_index.cohort | 85 |
| abstract_inverted_index.direct | 50 |
| abstract_inverted_index.highly | 97 |
| abstract_inverted_index.immune | 206 |
| abstract_inverted_index.killer | 20 |
| abstract_inverted_index.kinase | 34 |
| abstract_inverted_index.relies | 2 |
| abstract_inverted_index.score, | 171 |
| abstract_inverted_index.subset | 139 |
| abstract_inverted_index.tumors | 47 |
| abstract_inverted_index.©2013 | 220 |
| abstract_inverted_index.(NCAM1) | 143 |
| abstract_inverted_index.73(12); | 218 |
| abstract_inverted_index.control | 23 |
| abstract_inverted_index.density | 156 |
| abstract_inverted_index.despite | 116 |
| abstract_inverted_index.effects | 51, 61 |
| abstract_inverted_index.largely | 29 |
| abstract_inverted_index.natural | 19 |
| abstract_inverted_index.optimal | 209 |
| abstract_inverted_index.status. | 179 |
| abstract_inverted_index.stromal | 46 |
| abstract_inverted_index.Evidence | 16 |
| abstract_inverted_index.T-helper | 11 |
| abstract_inverted_index.conserve | 111 |
| abstract_inverted_index.distinct | 187 |
| abstract_inverted_index.enriched | 104 |
| abstract_inverted_index.findings | 200 |
| abstract_inverted_index.imatinib | 36, 117, 152 |
| abstract_inverted_index.indirect | 59 |
| abstract_inverted_index.markedly | 38 |
| abstract_inverted_index.mesylate | 37, 118, 153 |
| abstract_inverted_index.missing. | 30 |
| abstract_inverted_index.patients | 43, 87, 213 |
| abstract_inverted_index.probably | 193 |
| abstract_inverted_index.profile. | 15 |
| abstract_inverted_index.prolongs | 39 |
| abstract_inverted_index.sections | 191 |
| abstract_inverted_index.survival | 41, 127 |
| abstract_inverted_index.tyrosine | 33 |
| abstract_inverted_index.Miettinen | 170 |
| abstract_inverted_index.Moreover, | 132 |
| abstract_inverted_index.activated | 98 |
| abstract_inverted_index.analyses. | 131 |
| abstract_inverted_index.densities | 121 |
| abstract_inverted_index.encourage | 201 |
| abstract_inverted_index.inhibitor | 35 |
| abstract_inverted_index.localized | 89 |
| abstract_inverted_index.predicted | 125, 162 |
| abstract_inverted_index.biomarkers | 207 |
| abstract_inverted_index.cell-based | 22 |
| abstract_inverted_index.especially | 103 |
| abstract_inverted_index.expressing | 77 |
| abstract_inverted_index.expression | 115 |
| abstract_inverted_index.infiltrate | 160 |
| abstract_inverted_index.mutational | 178 |
| abstract_inverted_index.prognostic | 71, 166 |
| abstract_inverted_index.treatment. | 119, 154 |
| abstract_inverted_index.validation | 204 |
| abstract_inverted_index.3499–510. | 219 |
| abstract_inverted_index.accumulated | 147 |
| abstract_inverted_index.contributed | 194 |
| abstract_inverted_index.distributed | 185 |
| abstract_inverted_index.homogeneous | 138 |
| abstract_inverted_index.infiltrated | 135 |
| abstract_inverted_index.information | 167 |
| abstract_inverted_index.lymphocytes | 75, 183 |
| abstract_inverted_index.prospective | 203 |
| abstract_inverted_index.investigated | 69 |
| abstract_inverted_index.malignancies | 26 |
| abstract_inverted_index.multivariate | 130 |
| abstract_inverted_index.independently | 161, 195 |
| abstract_inverted_index.preferentially | 184 |
| abstract_inverted_index.stratification | 211 |
| abstract_inverted_index.<i>Cancer | 216 |
| abstract_inverted_index.effector/memory | 4 |
| abstract_inverted_index.gastrointestinal | 45 |
| abstract_inverted_index.progression-free | 126 |
| abstract_inverted_index.immunostimulatory | 60 |
| abstract_inverted_index.cytokine-secreting | 141 |
| abstract_inverted_index.immunosurveillance | 1 |
| abstract_inverted_index.tumor-infiltrating | 5, 74 |
| abstract_inverted_index.immunosurveillance. | 198 |
| abstract_inverted_index.CD3<sup>+</sup> | 94, 123 |
| abstract_inverted_index.CD8<sup>+</sup> | 6 |
| abstract_inverted_index.(T<sub>H</sub>1) | 14 |
| abstract_inverted_index.CD56<sup>bright</sup> | 142 |
| abstract_inverted_index.<div>Abstract<p>Cancer | 0 |
| abstract_inverted_index.AACR</i>.</p></div> | 221 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 32 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6399999856948853 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.4367723 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |